Equibles does not estimate personal net worth.
Get an email with a short summary when Integra Lifesciences Holdings Corp publishes a filing, an earnings call transcript or a press release.
Get IART alertsIntegra Lifesciences Holdings Corp reported in an 8-K filed May 5, 2026 that Michael McBreen was appointed Chief Commercial Officer, effective May 1, 2026. The proxy statement of Integra Lifesciences Holdings Corp reports total compensation of $3,160,291 for Michael McBreen in fiscal 2024, including a base salary of $638,702. Disclosed compensation is on record for 5 fiscal years. Michael McBreen has spoken on 1 investor event across 1 company, most recently for Integra Lifesciences Holdings Corp on September 9, 2026. Integra Lifesciences Holdings Corp is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Integra Lifesciences Holdings Corp includes Dr. Stuart M. Essig (CEO), Mojdeh Poul (CEO and Board Member), Stuart M. Essig (CEO and Chairman) and 7 others.
“On May 5, 2026, the Company also announced the appointment of Michael McBreen, the Company’s Executive Vice President, President, Codman Specialty Surgical, as Chief Commercial Officer effective as of the Start Date.”
“So we do expect growth this year to contribute to overall enterprise growth. but we do you know in terms of what that business has the potential to do we expect kind of more mid single to high single digit growth and we do anticipate in 2027 for us to demonstrate an ability to get back to that trajectory I think…”
Proxy statement
Start not stated–present
Last confirmed April 6, 2026
Medical Devices · Healthcare
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Integra Lifesciences Holdings Corp (IART) | Executive Vice President, President, Codman Specialty Surgical | $638,702 | $3,160,291 |
| 2023 | Integra Lifesciences Holdings Corp (IART) | Executive Vice President, President, Codman Specialty Surgical | $598,077 | $2,830,152 |
| 2022 | Integra Lifesciences Holdings Corp (IART) | Executive Vice President, President, Codman Specialty Surgical | $494,469 | $2,148,582 |
| 2021 | Integra Lifesciences Holdings Corp (IART) | Executive Vice President, President, Codman Specialty Surgical | $459,969 | $1,880,367 |
| 2020 | Integra Lifesciences Holdings Corp (IART) | Executive Vice President, President, Codman Specialty Surgical | $385,308 | $1,274,273 |
